In this issue of Deep Dive we look at the changing landscape for pharma market access and start to assess the impact of the COVID-19 pandemic. Deep Dive: Market Access - Breaking Barriers also ...

Market access issues don’t stop once a product has passed HTA – and this is especially true for disruptive therapies like ATMPs. Experts from Executive Insight discuss how a holistic, multi ...

In the latest expansion of Destiny 2, titled The Edge of Fate, almost all PvE content has undergone significant changes. A ...